| Joseph Borer, MD | |
|
360 Broadway, Bangor, ME 04401-3979 | |
| (207) 907-3000 | |
| Not Available |
| Full Name | Joseph Borer |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 33 Years |
| Location | 360 Broadway, Bangor, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386605095 | NPI | - | NPPES |
| 42611 | Other | MN | MN MEDICAL LICENSE |
| 610935700 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 42611 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hilo Medical Center | Hilo, HI | Hospital |
| Kau Hospital | Pahala, HI | Hospital |
| Hale Ho'ola Hamakua | Honokaa, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hawaii Emergency Physicians Associated Inc | 2860390283 | 73 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
The rule, which was issued Friday, proposed a way for women who work at nonprofit religious institutions to get free birth control without requiring their employers to pay for it.
Heart attack, or myocardial infarction, is one of the leading causes of death worldwide. Although modern surgical techniques, diagnostics and medications have greatly improved early survival from these events, many patients struggle with the long-term effects of permanently damaged tissue, and the 5-year mortality rate remains high.
Individuals with prediabetes have a significantly reduced risk for progressing to full diabetes if they have a history of reverting to normal glucose regulation, show US study findings.
› Verified 7 days ago
| Entity Name | Hawaii Emergency Physicians Associated Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801843198 PECOS PAC ID: 2860390283 Enrollment ID: O20040127001137 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
The rule, which was issued Friday, proposed a way for women who work at nonprofit religious institutions to get free birth control without requiring their employers to pay for it.
Heart attack, or myocardial infarction, is one of the leading causes of death worldwide. Although modern surgical techniques, diagnostics and medications have greatly improved early survival from these events, many patients struggle with the long-term effects of permanently damaged tissue, and the 5-year mortality rate remains high.
Individuals with prediabetes have a significantly reduced risk for progressing to full diabetes if they have a history of reverting to normal glucose regulation, show US study findings.
› Verified 7 days ago
| Entity Name | Kau Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144304338 PECOS PAC ID: 7416945548 Enrollment ID: O20040601000398 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
The rule, which was issued Friday, proposed a way for women who work at nonprofit religious institutions to get free birth control without requiring their employers to pay for it.
Heart attack, or myocardial infarction, is one of the leading causes of death worldwide. Although modern surgical techniques, diagnostics and medications have greatly improved early survival from these events, many patients struggle with the long-term effects of permanently damaged tissue, and the 5-year mortality rate remains high.
Individuals with prediabetes have a significantly reduced risk for progressing to full diabetes if they have a history of reverting to normal glucose regulation, show US study findings.
› Verified 7 days ago
| Entity Name | Hale Ho'ola Hamakua |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164506317 PECOS PAC ID: 7810926029 Enrollment ID: O20200304002483 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
The rule, which was issued Friday, proposed a way for women who work at nonprofit religious institutions to get free birth control without requiring their employers to pay for it.
Heart attack, or myocardial infarction, is one of the leading causes of death worldwide. Although modern surgical techniques, diagnostics and medications have greatly improved early survival from these events, many patients struggle with the long-term effects of permanently damaged tissue, and the 5-year mortality rate remains high.
Individuals with prediabetes have a significantly reduced risk for progressing to full diabetes if they have a history of reverting to normal glucose regulation, show US study findings.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Borer, MD 360 Broadway, Bangor, ME 04401-3979 Ph: (207) 907-3000 | Joseph Borer, MD 360 Broadway, Bangor, ME 04401-3979 Ph: (207) 907-3000 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
The rule, which was issued Friday, proposed a way for women who work at nonprofit religious institutions to get free birth control without requiring their employers to pay for it.
Heart attack, or myocardial infarction, is one of the leading causes of death worldwide. Although modern surgical techniques, diagnostics and medications have greatly improved early survival from these events, many patients struggle with the long-term effects of permanently damaged tissue, and the 5-year mortality rate remains high.
Individuals with prediabetes have a significantly reduced risk for progressing to full diabetes if they have a history of reverting to normal glucose regulation, show US study findings.
› Verified 7 days ago
James Hildebrand, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 Broadway, Bangor, ME 04401 Phone: 207-907-1703 Fax: 207-907-1921 | |
Mr. Angus Lee Hollander Beal, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-8000 Fax: 207-973-7985 | |
Ivan King, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 360 Broadway, Bangor, ME 04401 Phone: 207-262-1703 Fax: 207-262-1106 | |
Dr. Ellen W White, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 489 State St, Emergency Department, Bangor, ME 04401 Phone: 207-973-7250 Fax: 207-973-5656 | |
Rose Mengual, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-5199 | |
Dr. Ruth A Fogler, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-8000 Fax: 207-973-5656 | |
Christian Andersen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 Broadway, Bangor, ME 04401 Phone: 207-907-3000 Fax: 207-907-1921 |